HHT1 and HHT2 patients are heterozygous for mutations in ENG or ALK1 genes, respectively; although recent work has revealed that vascular lesions from HHT patients contain cells with a local second mutation in the ‘good’ allele (ENG or ALK1). The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.